Program for prostate cancer screening using a mobile unit: Results from Brazil

Urology

Volumn 76, Issue 5, 2010, Pages 1052-1057

  Faria, Eliney F ^a,b   Carvalhal, Gustavo F ^a   Vieira, René A C ^a   Silva, Thiago B ^a   Mauad, Edmundo C ^a   Carvalho, André L ^a,b  

^a BARRETOS CANCER HOSPITAL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAZIL; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HEALTH PROGRAM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

AGED; BIOPSY, NEEDLE; BRAZIL; DIGITAL RECTAL EXAMINATION; EARLY DETECTION OF CANCER; HUMANS; MALE; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; MOBILE HEALTH UNITS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 78149357602     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.02.044     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. INCA/Brasil Ministrio da Sade Secretaria de Assistência Sade. Rio de Janeiro, Instituto Nacional do Cncer, 2009, vol. 2009 www.inca.gov.br Accessed on November 15, 2009.
3. F.H. Schrder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
4. G.L. Andriole, E.D. Crawford, and R.L. Grubb III Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
5. R.A. Smith, V. Cokkinides, and O.W. Brawley Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin 59 2009 27 41
6. C. Bouchardy, G. Fioretta, and E. Rapiti Recent trends in prostate cancer mortality show a continuous decrease in several countries Int J Cancer 123 2008 421 429
7. M.P. Coleman, M. Quaresma, and F. Berrino Cancer survival in five continents: a worldwide population-based study (CONCORD) Lancet Oncol 9 2008 730 756
8. E.J. Bergstralh, R.O. Roberts, and S.A. Farmer Population-based case-control study of PSA and DRE screening on prostate cancer mortality Urology 70 2007 936 941
9. C.D. Scales Jr, J. Antonelli, and L.H. Curtis Prostate-specific antigen screening among young men in the United States Cancer 113 2008 1315 1323
10. M. Kuwahara, T. Tochigi, and S. Kawamura Mass screening for prostate cancer: a comparative study in Natori, Japan and Changchun, China Urology 61 2003 137 141
11. E.L. Paschoalin, A.C. Martins, and M. Pastorello Racial influence on the prevalence of prostate carcinoma in Brazilian volunteers Int Braz J Urol 29 2003 300 305
12. J. Stenner, E.P. DeAntoni, and C. O'Donnell Prevalence and natural history of urinary symptoms in a longitudinal national prostate cancer screening (community-based) study Prostate Cancer Prostatic Dis 1 1998 256 261
13. W.J. Catalona, J.P. Richie, and F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283 1290
14. E.D. Crawford, S. Leewansangtong, and S. Goktas Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values Prostate 38 1999 296 302
15. R.C. Flanigan, W.J. Catalona, and J.P. Richie Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer J Urol 152 1994 1506 1509
16. G.F. Carvalhal, D.S. Smith, and D.E. Mager Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng/ml or less J Urol 161 1999 835 839
17. J.S. Krumholtz, G.F. Carvalhal, and C.G. Ramos Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features Urology 60 2002 469 474
18. American Urological Association Prostate-Specific Antigen Best Practice Statement: 2009 Update 2009 American Urological Association Linthicum, MD
19. W.J. Catalona, D.S. Smith, and D.K. Ornstein Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4 ng/ml and benign prostate examination: enhancement of specificity with free PSA measurements JAMA 277 1997 1452 1455
20. National Comprehensive Cancer Network NCCN Prostate Cancer GuidelinesEarly Detection Vol. v.1.2010 2009 National Comprehensive Cancer Network Fort Washington, PA
21. R.L. Grubb III, P.F. Pinsky, and R.T. Greenle Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial BJU Int 102 2008 1524 1530
22. S. Loeb, C.M. Gonzalez, and K.A. Roehl Pathological characteristics of prostate cancer detected through prostate specific based screening J Urol 175 2006 902 906
23. R. Postma, F.H. Schroder, and G.J. van Leenders Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)Section Rotterdam: a comparison of two rounds of screening Eur Urol 52 2007 89 97
24. D.S. Smith, P.A. Humphrey, and W.J. Catalona The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience Cancer 80 1997 1852 1856
25. D.S. Smith, W.J. Catalona, and J.C. Herschman Longitudinal screening for prostate cancer with prostate-specific antigen JAMA 276 1996 1309 1315
26. W.J. Catalona, A.W. Partin, and K.M. Slawin Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial JAMA 279 1998 1542 1547
27. W.J. Catalona, P.C. Southwick, and K.M. Slawin Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging Urology 56 2000 255 260
28. J.A. Efstathiou, M.H. Chen, and W.J. Catalona Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality Urology 68 2006 342 347
29. H. Singh, E.I. Canto, and S.F. Shariat Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy J Urol 171 2004 1089 1092
30. G.L. Andriole, D.L. Levin, and E.D. Crawford Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial J Natl Cancer Inst 97 2005 433 438